# A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions

> **NCT03898011** · PHASE1 · COMPLETED · sponsor: **Pharmtechnology LLC** · enrollment: 28 (actual)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** Lamotrigine
- **DRUG:** Lamictal

## Key facts

- **NCT ID:** NCT03898011
- **Lead sponsor:** Pharmtechnology LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-23
- **Primary completion:** 2019-05-04
- **Final completion:** 2019-05-04
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03898011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03898011, "A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03898011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*